(888) 39-MERCY
Wisconsin & Illinois

Health Library


Return to Index
by EBSCO Medical Review Board

Reducing Your Risk of Scleroderma

There are no known ways to lower the risk of this health problem.

References

Kowal-Bielecka O, Fransen J, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017 Aug;76(8):1327-1339.
Localized scleroderma. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/localized-scleroderma. Accessed August 12, 2020.
Scleroderma. National Institute of Arthritis and Musculoskeletal and Skin Diseases website. Available at: https://www.niams.nih.gov/Health%5FInfo/Scleroderma/default.asp. Accessed August 12, 2020.
Systemic sclerosis. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/systemic-sclerosis. Accessed August 12, 2020.
What is scleroderma? Scleroderma Foundation website. Available at: http://www.scleroderma.org/site/PageServer?pagename=patients%5Fwhatis#.WEhnf02QzIV. Accessed August 12, 2020.

Revision Information

  • Reviewer: EBSCO Medical Review Board James P. Cornell, MD
  • Review Date: 03/2020
  • Update Date: 03/09/2021